TY - JOUR
T1 - Predictors of walking capacity in peripheral arterial disease patients
AU - Farah, Breno Quintella
AU - Souza Barbosa, João Paulo dos Anjos
AU - Cucato, Gabriel Grizzo
AU - Chehuen, Marcel da Rocha
AU - Gobbo, Luis Alberto
AU - Wolosker, Nelson
AU - Forjaz, Cláudia Lúcia de Moraes
AU - Ritti-Dias, Raphael Mendes
PY - 2013/4/25
Y1 - 2013/4/25
N2 - OBJECTIVE: To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire.METHODS: The sample included 133 intermittent claudication patients of both genders aged between 30 and 80 years. Data regarding clinical characteristics, the walking impairment questionnaire and treadmill walking test performance were obtained. Multiple regression modeling was conducted to predict claudication onset distance and total walking distance using clinical characteristics (age, height, mass, body mass index, ankle brachial index lower, gender, history of smoking and co-morbid conditions) and walking impairment questionnaire responses. Comparisons of claudication onset distance and total walking distance measured during treadmill tests and estimated by a regression equation were performed using paired t-tests.RESULTS: Co-morbid conditions (diabetes and coronary artery disease) and questions related to difficulty in walking short distances (walking indoors - such as around your house and walking 5 blocks) and at low speed (walking 1 block at average speed - usual pace) resulted in the development of new prediction models high significant for claudication onset distance and total walking distance (p<0.001). In addition, non-significant differences from the results obtained by the treadmill test and estimated by the current model (p>0.05) were observed.CONCLUSION: The current study demonstrated that walking capacity can be adequately estimated based on co-morbid conditions and responses to the walking impairment questionnaire.
AB - OBJECTIVE: To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire.METHODS: The sample included 133 intermittent claudication patients of both genders aged between 30 and 80 years. Data regarding clinical characteristics, the walking impairment questionnaire and treadmill walking test performance were obtained. Multiple regression modeling was conducted to predict claudication onset distance and total walking distance using clinical characteristics (age, height, mass, body mass index, ankle brachial index lower, gender, history of smoking and co-morbid conditions) and walking impairment questionnaire responses. Comparisons of claudication onset distance and total walking distance measured during treadmill tests and estimated by a regression equation were performed using paired t-tests.RESULTS: Co-morbid conditions (diabetes and coronary artery disease) and questions related to difficulty in walking short distances (walking indoors - such as around your house and walking 5 blocks) and at low speed (walking 1 block at average speed - usual pace) resulted in the development of new prediction models high significant for claudication onset distance and total walking distance (p<0.001). In addition, non-significant differences from the results obtained by the treadmill test and estimated by the current model (p>0.05) were observed.CONCLUSION: The current study demonstrated that walking capacity can be adequately estimated based on co-morbid conditions and responses to the walking impairment questionnaire.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Ankle Brachial Index
KW - Body Mass Index
KW - Exercise Test
KW - Female
KW - Humans
KW - Intermittent Claudication/physiopathology
KW - Male
KW - Middle Aged
KW - Peripheral Arterial Disease/physiopathology
KW - Predictive Value of Tests
KW - Reproducibility of Results
KW - Risk Factors
KW - Surveys and Questionnaires
KW - Walking/physiology
U2 - 10.6061/clinics/2013(04)16
DO - 10.6061/clinics/2013(04)16
M3 - Article
C2 - 23778336
VL - 68
SP - 537
EP - 541
JO - Clinics
JF - Clinics
SN - 1807-5932
IS - 4
ER -